Wordt geladen...
Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema
Diabetic retinopathy (DR) is the most common cause of visual loss among working age individuals. Diabetic macular edema (DME) is an important complication of DR that affects around one third of the patients with DR. Several treatments have been approved for DME ranging from blood pressure and glycem...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Co., Limited
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3874490/ https://ncbi.nlm.nih.gov/pubmed/24379921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.303 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|